Kynexis: Funding, Investors & Team (Oct 2026)
Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).
Kynexis has raised $46.3M across 1 funding round on record, the most recent a Series A of $46.3M announced in Aug 2026.
That round is above the $3.3M median round size for The Netherlands companies tracked on FundedIQ over the last two years.
Kynexis Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Kynexis Funding Rounds
Kynexis Investors
Kynexis Founders and Leadership Team
Contact details for the Kynexis team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Kynexis Funding in Context
Kynexis' latest round of $46.3M is above the median round in The Netherlands. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kynexis in Biotechnology and Naarden
Companies Similar to Kynexis
Booomtag provides NFC, RFID, and QR-based product tagging with a cloud platform for product registration and…
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by…
Duqu provides short-term business financing by advancing money on outstanding business-to-business invoices.
Euclyd develops AI infrastructure designed to make advanced AI computing more efficient and scalable.
Persistent, forkable and suspendable virtual machines for agents and agentic workloads.
UCANACT is a digital assistive technology paired with wearables or implants to give motor-disabled…
Custodea is a data platform that brings business data from multiple software systems into one private data…
Fortaegis Technologies designs and develops semiconductors for collaborative intelligent systems.
Majoop connects jobseekers, employers, and recruiters with tools for discovery, collaboration, and automated…
AI-native back office platform automating business banking, accounting, and tax for founders.
World's first AI Hearing Health Platform
Ore Energy develops long-duration energy storage systems for renewable energy applications and electric power…
Kynexis Funding FAQs
What does Kynexis do?
Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).
How much funding has Kynexis raised?
Kynexis has raised $46.3M across 1 round on record. The most recent is a Series A of $46.3M announced in Aug 2026.
When did Kynexis last raise funding?
Kynexis' most recent funding round on record is a Series A of $46.3M, announced in Aug 2026.
Who has invested in Kynexis?
Investors on record for Kynexis include Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures, Novartis Venture Fund.
Where is Kynexis headquartered?
Kynexis is based in Naarden, The Netherlands.
How many employees does Kynexis have?
Kynexis is in the 11-50 employee band.
When was Kynexis founded?
Kynexis was founded in 2023.
About FundedIQ's Kynexis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kynexis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.